ATE109158T1 - Rubella-e1 und c peptide. - Google Patents

Rubella-e1 und c peptide.

Info

Publication number
ATE109158T1
ATE109158T1 AT90911900T AT90911900T ATE109158T1 AT E109158 T1 ATE109158 T1 AT E109158T1 AT 90911900 T AT90911900 T AT 90911900T AT 90911900 T AT90911900 T AT 90911900T AT E109158 T1 ATE109158 T1 AT E109158T1
Authority
AT
Austria
Prior art keywords
rubella
peptides
rubella virus
useful
analogues
Prior art date
Application number
AT90911900T
Other languages
English (en)
Inventor
Martial Lacroix
Maan Zrein
Gervais Dionne
Original Assignee
Biochem Immunosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Immunosystems Inc filed Critical Biochem Immunosystems Inc
Application granted granted Critical
Publication of ATE109158T1 publication Critical patent/ATE109158T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90911900T 1989-08-23 1990-08-17 Rubella-e1 und c peptide. ATE109158T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/397,767 US5164481A (en) 1989-08-23 1989-08-23 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus

Publications (1)

Publication Number Publication Date
ATE109158T1 true ATE109158T1 (de) 1994-08-15

Family

ID=23572541

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90911900T ATE109158T1 (de) 1989-08-23 1990-08-17 Rubella-e1 und c peptide.

Country Status (12)

Country Link
US (2) US5164481A (de)
EP (1) EP0491713B1 (de)
JP (1) JP3317967B2 (de)
AT (1) ATE109158T1 (de)
AU (1) AU646641B2 (de)
CA (1) CA2065022C (de)
DE (1) DE69011122T2 (de)
DK (1) DK0491713T3 (de)
ES (1) ES2057579T3 (de)
HU (1) HUT60508A (de)
OA (1) OA09653A (de)
WO (1) WO1991002748A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
US5510264A (en) * 1993-09-28 1996-04-23 Insight Biotech Inc. Antibodies which bind meningitis related homologous antigenic sequences
US6180758B1 (en) * 1994-10-06 2001-01-30 Connaught Laboratories Limited Synthetic peptides for rubella vaccine
EP1135684B1 (de) 1998-12-01 2006-01-11 Viral Antigens, Inc. VERBESSERTE SPEZIFITÄT IN DER DETEKTION DER ANTI-RUBELLA IgM ANTIKÖRPER
JP2010519916A (ja) * 2007-03-06 2010-06-10 リボバックス バイオテクノロジーズ ソシエテ アノニム 風疹ウイルスに特異的な抗体
CN101402960B (zh) * 2008-08-13 2011-05-11 吴丽霞 一种重组风疹病毒e1蛋白及其应用
US8734798B2 (en) * 2009-10-27 2014-05-27 Ucb Pharma S.A. Function modifying NAv 1.7 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
GB2206587A (en) * 1987-07-08 1989-01-11 London Biotechnology Ltd Rubella e1 glycoprotein antigens

Also Published As

Publication number Publication date
WO1991002748A1 (en) 1991-03-07
AU646641B2 (en) 1994-03-03
US5298596A (en) 1994-03-29
JP3317967B2 (ja) 2002-08-26
US5164481A (en) 1992-11-17
EP0491713A1 (de) 1992-07-01
DK0491713T3 (da) 1994-09-26
AU6151790A (en) 1991-04-03
OA09653A (en) 1993-05-15
CA2065022A1 (en) 1991-02-24
HU9200583D0 (en) 1992-05-28
JPH04507409A (ja) 1992-12-24
DE69011122D1 (de) 1994-09-01
HUT60508A (en) 1992-09-28
CA2065022C (en) 2001-11-20
DE69011122T2 (de) 1994-11-10
ES2057579T3 (es) 1994-10-16
EP0491713B1 (de) 1994-07-27

Similar Documents

Publication Publication Date Title
FI913560A7 (fi) Synteettiset peptidit, erikoisesti HCV:n vasta-aineiden havaitsemiseen, HCV infektion diagnoosiin ja sen estämiseen rokotteina
ATE154808T1 (de) Peptide mit den immunologischen eigenschaften von hiv-2
FI882173A7 (fi) Synteettinen peptidiantigeeni HIV-2-tartunnan toteamiseksi.
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ATE125821T1 (de) Vakzin gegen hepatitis b.
BR8701528A (pt) Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
WO1992017493A3 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
DE69232906D1 (de) Detektion des Hepatis-C Virus.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
ATE109158T1 (de) Rubella-e1 und c peptide.
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE308618T1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
DK0704528T3 (da) Hæmorrhagisk sygdomsvirus hos kaniner (RHDV), rekombinante capsider og proteiner, diagnostiske kits og vacciner indeholdende dem
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
FI923020A0 (fi) Inte a inte b-sekvenser.
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
FI952779L (fi) HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
ATE540052T1 (de) Neue peptide, die epitope des humanen herpesvirus 8 darstellen
FI952778L (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
EP0808846A3 (de) Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee